Saizen: profile and news

Rodman & Renshaw 3rd Annual Global Healthcare Conference 2006 ...  May 11, 2006
The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R)/ Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R ... - Genetic Engineering News,

Serono Announces New Appointments to its Executive Management ...  May 9, 2006
The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R )/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R ... - PharmaLive.com (press release),

Novartis Unit Gets Approval For Copycat of Biotech Drug  Apr 18, 2006
...obtained approval for the recombinant human growth hormone Omnitrope, a biosimilar, or generic version, of Pfizer Inc.'s Genotropin and Serono SA's Saizen. ... - Wall Street Journal (subscription),

Serono Delivers Strong First Quarter 2006 With Revenue Growth of ...  Apr 19, 2006
Saizen® sales increased by 4.4%, or 10.0% in local currencies, to $49.9m (Q1 2005: $47.8m). Saizen® continues to be differentiated using the innovative ... - Yahoo! News (press release)

Serono Delivers Strong First Quarter 2006 With Revenue Growth of ...  Apr 19, 2006
...sales of supporting products (Ovidrel(R), Cetrotide(R), Crinone(R) and Luveris(R)) were up 11.3%, or 16.6% in local currencies, to $22.6m. Saizen(R) sales ... - PR Newswire (press release),

Serono Announces New Appointments to its Executive Management ...  May 8, 2006
The Company has eight biotechnology products, Rebif®, Gonal-f®, Luveris®, Ovidrel(R )/Ovitrelle®, Serostim®, Saizen®, Zorbtive(TM) and Raptiva®. ... - Yahoo! News (press release)

Phase III Trial Of Oral Cladribine, A Novel Investigational ...  May 5, 2006
Ovidrel PreFilled Syringe(R)/Ovitrelle(R) (choriogonadotropin alfa injection), Serostim(R) [somatropin (rDNA origin) for injection], Saizen(R) [somatropin ... - Medical News Today (press release),

Serono Shareholders Approve Resolutions at Annual General Meeting  Apr 25, 2006
The Company has eight biotechnology products, Rebif®, Gonal-f®, Luveris®, Ovidrel® /Ovitrelle®, Serostim®, Saizen®, Zorbtive(TM) and Raptiva®. ... - Yahoo! News (press release)

Serono Shareholders Approve Resolutions at Annual General Meeting  Apr 25, 2006
The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R) /Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R ... - PharmaLive.com (press release),